World Orphan Drug Congress USA Virtual 2021

The conference brings together pharma, biotechs, government, payers, investors and patient/patient advocates in the rare disease space to discuss the latest developments that will lead to the future of orphan drug development.

We are thrilled to announce some amazing speakers participating in the World Orphan Drug Congress Americas Virtual that you cannot afford to miss...

1. Yann Le Cam, Chief Executive Officer, Eurordis – Rare Diseases Europe
2. Peter Saltonstall, CEO, National Organization for Rare Disorders (NORD)
3. Durhane Wong-Rieger, President And Chief Executive Officer, Canadian Organization For Rare Disorders
4. Lisa Deschamps, Chief Business Officer, Novartis Gene Therapies
5. Reda Guiha, Regional President of International Developed Markets – Rare Disease Division, Pfizer
6. Peter Marks, Director, Center for Biologics Evaluation and Research (CBER), FDA